Medicine and Dentistry
Cohort Analysis
100%
B-Cell Chronic Lymphocytic Leukemia
53%
Myeloproliferative Neoplasm
45%
Malignant Neoplasm
43%
Idiopathic Thrombocytopenic Purpura
38%
Diseases
33%
Comorbidity
32%
Diffuse Large B-Cell Lymphoma
30%
Evans Syndrome
27%
Hazard Ratio
23%
Infection
22%
COVID-19
20%
Prevalence
20%
Multiple Myeloma
19%
Platelet
19%
Cancer
19%
Overall Survival
18%
Quality of Life
17%
Ibrutinib
16%
Hematological Cancer
16%
Acute Myeloid Leukemia
15%
Cardiovascular Disease
14%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Hematologic Malignancy
14%
International Prognostic Index
13%
Myelodysplastic Syndrome
12%
Venetoclax
12%
Hemolytic
12%
Hodgkin's Lymphoma
11%
Systematic Review
11%
Disease
11%
Essential Thrombocythaemia
10%
Polycythemia vera
10%
Non-Hodgkin Lymphoma
10%
Thrombocyte Aggregation
9%
Minimal Residual Disease
9%
Cancer Diagnosis
8%
Cardiovascular System
8%
Retrospective Cohort Study
8%
Patient-Reported Outcome
8%
Cohort Effect
8%
Osteoporosis
8%
Neoplasm
8%
Oncology
8%
Thrombocytopenia
8%
C Reactive Protein
8%
Mental Health
7%
Thrombocyte Function
7%
Erythrocyte
7%
Serum Albumin
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
72%
Malignant Neoplasm
58%
Chronic Lymphatic Leukemia
58%
Idiopathic Thrombocytopenic Purpura
56%
Infection
27%
Overall Survival
27%
Diseases
25%
Comorbidity
24%
Autoimmune Hemolytic Anemia
23%
Myeloproliferative Neoplasm
22%
SARS Coronavirus
19%
Diffuse Large B Cell Lymphoma
18%
Hematologic Malignancy
17%
Rituximab
17%
Myelodysplastic Syndrome
16%
Multiple Myeloma
16%
Ibrutinib
14%
Prevalence
12%
Hematologic Disease
11%
Mortality Rate
10%
Psychotropic Agent
9%
Cardiovascular Disease
9%
Venetoclax
8%
Remission
8%
Cyclophosphamide
8%
Chemotherapy
8%
Brain Ischemia
8%
Acute Myeloid Leukemia
8%
Polycythemia vera
7%
Thrombocythemia
7%
Progression Free Survival
7%
Nonhodgkin Lymphoma
7%
Proton Pump Inhibitor
7%
Paroxysmal Nocturnal Hemoglobinuria
7%
Prednisolone
7%
Venous Thromboembolism
7%
Adverse Event
6%
Monotherapy
6%
Clinical Trial
6%
Heart Infarction
6%
Bleeding
5%
C Reactive Protein
5%
Severe Acute Respiratory Syndrome
5%
Acute Leukemia
5%
CD20 Antibody
5%
Fludarabine
5%
Receptor Agonist
5%
Thrombopoietin Receptor
5%
Bendamustine
5%
Thrombocytopenia
5%
